MedPath
NMPA Approval

富马酸替诺福韦二吡呋酯

国药准字H20173158

April 12, 2022

国药准字H20173158/Y20190000041

Drug Information

富马酸替诺福韦二吡呋酯

化学药品

April 12, 2022

Company Information

Applicant Company

Manufacturing Company

深泽县工业园区(西环路16号)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

富马酸替诺福韦二吡呋酯 - NMPA 批准文号 | MedPath